Rong-rong Zhu

Nanchang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Circular RNA circFTO promotes pressure overload-induced cardiac hypertrophy by encoding a novel protein FTO-36aa.

Circular RNA circFTO promotes pressure overload-induced cardiac hypertrophy by encoding a novel protein FTO-36aa.

Journal: Journal of thoracic disease

Published: July 18, 2025

NSD2 mediated H3K36me2 promotes pulmonary arterial hypertension by recruiting FOLR1 and metabolism reprogramming.

NSD2 mediated H3K36me2 promotes pulmonary arterial hypertension by recruiting FOLR1 and metabolism reprogramming.

Journal: Cellular signalling

Published: September 14, 2024

NSD2 promotes pressure overload-induced cardiac hypertrophy via activating circCmiss1/TfR1/ferroptosis signaling.

NSD2 promotes pressure overload-induced cardiac hypertrophy via activating circCmiss1/TfR1/ferroptosis signaling.

Journal: Life sciences

Published: April 28, 2023

Keap-NRF2 signaling contributes to the Notch1 protected heart against ischemic reperfusion injury via regulating mitochondrial ROS generation and bioenergetics.

Keap-NRF2 signaling contributes to the Notch1 protected heart against ischemic reperfusion injury via regulating mitochondrial ROS generation and bioenergetics.

Journal: International journal of biological sciences

Published: May 31, 2021

Notch1-Nrf2 signaling crosstalk provides myocardial protection by reducing ROS formation.

Notch1-Nrf2 signaling crosstalk provides myocardial protection by reducing ROS formation.

Journal: Biochemistry and cell biology = Biochimie et biologie cellulaire

Published: February 19, 2020

Inhibition of the Notch1 pathway induces peripartum cardiomyopathy.

Inhibition of the Notch1 pathway induces peripartum cardiomyopathy.

Journal: Journal of cellular and molecular medicine

Published: September 24, 2019

Notch1 protects against myocardial ischaemia-reperfusion injury via regulating mitochondrial fusion and function.

Notch1 protects against myocardial ischaemia-reperfusion injury via regulating mitochondrial fusion and function.

Journal: Journal of cellular and molecular medicine

Published: August 11, 2019

NSD2 silencing alleviates pulmonary arterial hypertension by inhibiting trehalose metabolism and autophagy.

NSD2 silencing alleviates pulmonary arterial hypertension by inhibiting trehalose metabolism and autophagy.

Journal: Clinical science (London, England : 1979)

Published: February 16, 2019

Notch signaling inhibits cardiac fibroblast to myofibroblast transformation by antagonizing TGF-β1/Smad3 signaling.

Notch signaling inhibits cardiac fibroblast to myofibroblast transformation by antagonizing TGF-β1/Smad3 signaling.

Journal: Journal of cellular physiology

Published: August 03, 2018

NSD2 promotes ventricular remodelling mediated by the regulation of H3K36me2.

NSD2 promotes ventricular remodelling mediated by the regulation of H3K36me2.

Journal: Journal of cellular and molecular medicine

Published: July 05, 2018

Notch1 provides myocardial protection by improving mitochondrial quality control.

Notch1 provides myocardial protection by improving mitochondrial quality control.

Journal: Journal of cellular physiology

Published: May 25, 2018

Notch signaling promotes angiogenesis and improves cardiac function after myocardial infarction.

Notch signaling promotes angiogenesis and improves cardiac function after myocardial infarction.

Journal: Journal of cellular biochemistry

Published: December 21, 2017

Showing 1-12 of 13

Last Updated: 09/26/2026